Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mawson Infrastructure Group Inc. Director's Dealing 2019

Apr 24, 2019

35202_dirs_2019-04-23_f2b0c309-0f95-4710-a187-5dc79eb11692.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-04-21

Reporting Person: Ridge Valley Corp (10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-21 Convertible Loans $1.1112 S 265531 Disposed 2019-05-31 Common Stock (265531) Direct
2019-04-21 Investment Rights $1.332 S 94382 Disposed 2019-11-30 Common Stock (94382) Direct

Footnotes

F1: Issuable upon the conversion of the convertible loans under the January 19, 2017 Loan Agreement (the "Loan Agreement") by and among the Issuer and Ridge Valley Corporation, among others. The Convertible Loans may be converted at any time.

F2: The purchaser waived a debt owed to him by Ridge Valley Corporation as consideration for these derivative securities.